Hershberg Robertinsider trades
In SEC Form 4 filings, Hershberg Robert is listed as Director of Recursion Pharmaceuticals, Inc. (RXRX) and Director of AtaiBeckley Inc. (ATAI). In the last 90 days, Hershberg Robert sold $125K of Recursion Pharmaceuticals, Inc. (RXRX) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.
Companies and roles
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-11
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RXRXRecursion Pharmaceuticals, Inc. | Oct 6 | Oct 7 | M | 25,000 | $2.22 | $55,500 | 187,156 | Yes | Form 4 |
| RXRXRecursion Pharmaceuticals, Inc. | Oct 6 | Oct 7 | S | 25,000 | $5.00 | Sale −$125,000 | 162,156 | Yes | Form 4 |
| RXRXRecursion Pharmaceuticals, Inc. | Oct 6 | Oct 7 | M · derivative | 25,000 | $2.22 | $55,500 | 500,000 | Yes | Form 4 |
| ATAIAtaiBeckley Inc. | Sep 11 | Sep 11 | D · derivative | 48,858 | $1.35 | $65,958 | not reported | No | Form 4 |
| ATAIAtaiBeckley Inc. | Sep 11 | Sep 11 | D · derivative | 404,869 | $1.35 | $546,573 | not reported | No | Form 4 |
| ATAIAtaiBeckley Inc. | Sep 11 | Sep 11 | D · derivative | 62,394 | $1.35 | $84,232 | not reported | No | Form 4 |
| ATAIAtaiBeckley Inc. | Sep 11 | Sep 11 | D · derivative | 103,000 | $4.48 | $461,440 | not reported | No | Form 4 |
| ATAIAtaiBeckley Inc. | Sep 11 | Sep 11 | D · derivative | 121,968 | $4.50 | $548,856 | not reported | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.